RxDoctor Payments Data

Leland Gilmore, DPM

Podiatrist · Alexandria, VANPI 1235135815

Payments from drug & device makers

What this record shows

This record is dominated by other: $154,600 of the $155,215 with a category attached, or 99.6%. Convatec Inc. accounts for 99.7% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $154,616, more than ten times the $246 reported in 2019. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$155,215in general payments, 2019–2025

Across 49 payments — averaging $3167.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$155K
  • Amgen$95
  • Biopro, Inc.$78
  • Organogenesis Inc.$68
  • Paratek Pharmaceuticals, Inc.$65
  • Melinta Therapeutics, LLC$47
  • plus $150 from 6 others

What the payments were for

  • Food & beverage$6150%
  • Other$154,600100%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$155,215 in reported general payments places this provider in the 95th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$391,867
Medicare patients
277
Services billed
5,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole135$3,354
Pregabalin126$3,312
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip62$2,130
Diclofenac Sodium76$1,488
Pentoxifylline47$1,393
Duloxetine Hcl14$676
CiclopiroxCiclopirox Olamine15$401
Mupirocin32$374
Sulindac39$343
Allopurinol41$264
Ammonium Lactate12$225
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$214
Gabapentin30$163
Cephalexin23$106
Baclofen11$60

Paid to pharmacies, not to this prescriber.

Other podiatrist in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →